MAR vs NKE: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-07.
Marriott International, Inc. Β· Consumer Cyclical
$359.06
-45.0% upside to fair value
Grade D
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+38.4% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+38.4%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR NKE
Current Price $359.06 $42.62
Fair Value Estimate $197.48 $58.98
Upside to Fair Value -45.0% +38.4%
Market Cap $95.2B $63.0B
Forward P/E 37.7x 27.9x
EV / EBITDA 29.5x 20.7x
Price / Sales 4.4x 1.4x
Price / FCF 29.3x 19.4x
Revenue Growth YoY -71.1% -9.8%
Gross Margin 6.0% 42.7%
Operating Margin 19.6% 8.0%
Return on Equity -78.5% 24.4%
Dividend Yield 0% 3.8%
FCF Yield 3.41% 5.2%
Analyst Consensus Hold Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International operates a global fee-driven, asset-light hotel business with a portfolio of over 30 brands and a strong competitive position in the travel lodging industry. The company benefits from a durable competitive moat supported by its brand strength, extensive network, and recurring franchise and management fees. However, recent financials show significant headwinds with a 71.1% y…
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric MAR NKE
Zone Low $148.11 $44.23
Zone High $167.86 $50.13
In Buy Zone? No Yes
← MAR Research    NKE Research β†’    All Research